Research progress of biomarkers in lupus nephritis / 中国医师进修杂志

ABSTRACT

Systemic lupus erythematosus (SLE) is a multiorgan autoimmune disease, and lupus nephritis (LN) is the most common and severe complication of systemic lupus erythematosus, and the diagnosis and treatment of LN is closely related to the prognosis of systemic lupus erythematosus. Recently, promising LN biomarkers have been discovered that will be expected to provide guidance for the diagnosis and treatment of lupus kidney.